Safe Omission of Cardiac Monitoring in Select Patients With HER2+ MBC During Long-Term Trastuzumab Use
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiotoxicity During Long-Term Trastuzumab Use in Patients With HER2-Positive Metastatic Breast Cancer: Who Needs Cardiac Monitoring?
Breast Cancer Res Treat 2021 Jan 04;[EPub Ahead of Print], NI Bouwer, TG Steenbruggen, J van Rosmalen, HN Rier, JJEM Kitzen, ML van Bekkum, AJT Tije, PC de Jong, JC Drooger, C Holterhues, CH Smorenburg, MJM Kofflard, E Boersma, GS Sonke, MD Levin, A JagerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.